BOSTON -- NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced that it has officially opened its "Proteomics/Multi-Omics Early Access Program," to life science researchers and to CLIA certified labs developing diagnostic applications. The Company is making a limited number of systems available [...]

Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide BURLINGAME, Calif. -- Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of Katy Miles to its Board of Directors, effective as of February 1, 2022. She joins recent addition David Smoller, General Partner [...]

Automated Liquid Handling Company Earns Investment to Drive Commercial Growth BOSTON -- Avidien announced today a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. Avidien CEO and Founder Rich Cote said, "The partnership with BroadOak is exciting and ushers in [...]

Abcam to license in VHH phage library(1) from Twist, complementing in-house recombinant antibody capabilities Abcam to develop and commercialize antibodies for diagnostic and research use, with Twist retaining rights for therapeutic applications Reinforces Abcam’s commitment to consistently improve industry standards and support the sector with best-in-class reagents CAMBRIDGE, England & SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ:TWST), [...]

Cytognos divestment is a first strategic step aimed at positioning Vitro as a new worldwide diagnostic player in their key market segments SEVILLE, Spain -- Vitro S.A, (www.vitro.bio) a privately held company headquartered in Seville, Spain, announced today the sale of Cytognos to Becton Dickinson and Company (BD). Cytognos is a company specializing in flow cytometry solutions for blood [...]

BOSTON, LAUSANNE, BORDEAUX, and MARSEILLE – SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of their partnership with Institut Paoli Calmettes (IPC), one of the 18 French Comprehensive Cancer Centers (CLCC), to further support the implementation, automatization, and accreditation of solid tumor tests, to include [...]

LEXINGTON, Ky. — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has added a new chemiluminescent substrate as part of the trusted K-Blue® product line. K-Blue Luminescent is a two-component, luminol-based substrate that offers high sensitivity, ranging from the nanogram down to the femtogram level. This new formula is optimized to emit maximum light at [...]

BUFFALO, N.Y. -- Purity Scientific LLC, a parent company of GenTech Scientific which is a leading provider and servicer of refurbished scientific instruments, announced that it has acquired Conquer Scientific. The acquisition combined two industry leaders, allowing us to be number one in the world with a robust service network, unmatched resources, and an unparalleled inventory of [...]

Small to mid-sized enterprises and academic medical centers will have access to scalable and flexible solutions Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share their [...]

Nina Capital, APEX Medical and Cambridge Enterprise invest in transformational open-source data technology – to deliver precision medicine at scale University of Cambridge technology spin-out Zetta Genomics announces that is has raised £2.5 million in new seed funding. The successful round secures leading global Venture Capital (VC) investment in the company’s XetaBase platform – a [...]